Sabine Pellett
11Patents
3h-index
14Co-inventors
53Inventor score
Filing activity: Jun 27, 2008 → Mar 24, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8778623B2 | Compositions and methods of using differentiated cells sensitized to botulinum neurotoxin | Physics | 7 | Active |
| US9217172B2 | Compositions and methods for toxigenicity testing | Emerging Cross-Sectional Technologies | 7 | Active |
| US9447405B2 | Regulation of specific spinal neurons regulating pain transmission via chimeric toxins | Chemistry; Metallurgy | 4 | Active |
| US8940477B2 | Method of detecting botulinum neurotoxin and antibodies that neutralize botulinum neurotoxin action | Physics | 2 | Active |
| US10022450B2 | Regulation of specific spinal neurons regulating pain transmission via chimeric toxins | Chemistry; Metallurgy | 2 | Active |
| US9453057B2 | Plasmid-encoded neurotoxin genes in Clostridium botulinum serotype A subtypes | Chemistry; Metallurgy | 1 | Active |
| US8435759B2 | Plasmid-encoded neurotoxin genes in Clostridium botulinum serotype A subtypes | Chemistry; Metallurgy | 1 | Active |
| US10688162B2 | Hybrid neurotoxins and uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US10751394B2 | Neurotoxins and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US12344635B2 | COVID-19 vaccine | Chemistry; Metallurgy | 0 | Active |
| US11491239B2 | Modified clostridial neurotoxins as vaccines and conjugate vaccine platforms | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.